Chairman John D. (Jay) Rockefeller IV today announced the witnesses testifying at the U.S. Senate Committee on Commerce, Science, and Transportation hearing this week on “Medication and Performance Enhancing Drugs in Horse Racing.” This hearing will examine the prevalence and use of medications and performance enhancing drugs in horse racing.
Medication and Performance Enhancing Drugs in Horse Racing
Full Committee Hearing
Date: Thursday, July 12, 2012
Hearing Start Time: 2:30 p.m.
Location: Room 253, Russell Senate Office Building
Mr. Barry Irwin, Chief Executive Officer, Team Valor International
Mr. Kent H. Stirling, Executive Director, Florida Horsemen's Benevolent & Protective Association Chairman, Medication Committee, National Horsemen's Benevolent & Protective Association
Mr. Jeffrey Gural, Chairman, Newmark Grubb Knight Frank Chairman and Managing Partner, American Racing and Entertainment, LLC
Mr. Jim Gagliano, President, The Jockey Club
Mr. Matthew Witman, National Director, American Quarter Horse Association
Mr. Marc Paulhus, Former Director of Equine Protection and Vice President, Humane Society
Mr. Ed Martin, President and CEO, Association of Racing Commissioners International
Dr. Sheila Lyons, DVM, Founder and Director, The American College of Veterinary Sports Medicine and Rehabilitation Founder and Director, Homecoming Farm, Inc.
Please note the hearing will be webcast live via the Senate Commerce Committee website. Refresh the Commerce Committee homepage 10 minutes prior to the scheduled start time to automatically begin streaming the webcast.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2017 Paulick Report.